Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants

Indian Pediatrics

Volumn 44, Issue 11, 2007, Pages 830-837

  Parikh, Tushar B ^a,b   Nanavati, Ruchi N ^a   Patankar, Chandrakant V ^a   Rao PN, Suman ^a   Bisure, Kishore ^a   Udani, Rekha H ^a   Mehta, Preeti ^a  

^a KEM HOSPITAL   (India)

^b Staff Accommodation   (Australia)

Author keywords

Antifungal prophylaxis; Candida; Fluconazole; Neonate; VLBW infants

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; NYSTATIN; PLACEBO; STEROID;

ARTICLE; CANDIDA ALBICANS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGUS ISOLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYCOSIS; NEWBORN; NEWBORN INTENSIVE CARE; POSITIVE END EXPIRATORY PRESSURE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VERY LOW BIRTH WEIGHT;

ANTIFUNGAL AGENTS; CANDIDIASIS; DOUBLE-BLIND METHOD; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT;

EID: 36448968641     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Late onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 63-71.
2. Chapman RL, Roger GF. Invasive Neonatal Candidiasis: An overview. Semin Perinatol 2003; 27: 352-356.
3. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1988; 17; 593-598.
4. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: Trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 1998; 17: 504-508.
5. Singh K, Chakrabarti A, Narang A, Gopalan S. Yeast colonisation and invasive fungal infection in preterm neonates in a tertiary care centre. Indian J Med Res 1999; 110: 169-173.
6. Kaufman D. Strategies for prevention of neonatal invasive candidiasis. Semin Perinatol 2003; 5: 414-428.
7. Baley JE. Neonatal candidiasis: the current challenge. Clin Pernatol 1991; 18: 263-280.
8. Baley JE, Kleigman RM, Boxerbaum B, Fanaroff AA. Fungal colonization in the very low birth weight infants. Pediatrics 1986; 78: 225-232.
9. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against Candidal rectal colonization in the very low birth weight infant. Pediatrics 2001; 107: 293-298.
10. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis J 2000; 30: 662-678.
11. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001; 345: 1660-1666.
12. Chander J. Candidiasis. In: Chander J, ed. Textbook of Medical Mycology, 2nd edn, New Delhi: Mehta Publishers 2002; p 212-230.
13. Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, et al. The changing face of care in candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 1 00: 617-623.
14. Narayanan S. Candidiasis with special reference to immunocompromised patients. Dissertation submitted for MD (Microbiology) at the University of Mumbai, Jan 2000.
15. Narang A, Agrawal PB, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Pediatr. 1998; 44: 104-108.
16. Bliss JM, Wellington M, Gigliotti F. Antifungal pharmacotherapy for neonatal candidiasis. Semin Perinatol 2003; 27: 365-374.
17. Narang A, Agrawal P, Chakraborti A, Kumar P. Fluconazole in the management of neonatal systemic candidiasis Indian Pediatr 1996; 33: 823-826.
18. Yoder BA. Resistant Candida parapsilosis associated with long term Fluconazole prophylaxis in an animal model. Pediatr Infect Dis J 2004; 23: 687-868.
19. Vazquez JA, Peng G, Sobel JD, Steele-Moore L, Schuman P, Holloway W. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virusinfected women receiving Fluconazole prophylaxis. Clin Infect Dis 2001; 33: 1069-1075.
20. Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibility of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994; 38: 1422-1424. 838-841